Company Lookup
عربي
 
 

Market News

This Month News

This Month News

send to a friend by email

PHARMACARE records net income of $2.32 million in 9M 2016

2016-11-01

According to the financial statements of Dar Al-shifa Pharmaceuticals Company PHARMACARE for the first nine months of the year, net profit after taxes reached 2,316,366 USD, compared with a net profit after taxes of 2,695,863 USD from the first nine months of 2016, a net decrease of 14.1%.. Total assets of the company reached 50,831,922 USD as of September 30th, 2016, compared to total assets of 45,615,682 USD as of December 31st, 2015, a net increase of 11.4%. Total liabilities of the company reached 24,356,645 USD as of September 30th, 2016, compared to total liabilities of 21,072,784 USD as of December 31st, 2015, a net increase of 15.6%. Net ownership equity of the company reached 26,475,277 USD as of September 30th, 2016, compared with a net ownership equity of 24,542,898 USD as of December 31st, 2015, a net increase of 7.9% in the first nine months.


 

2024-04-15
TPIC proposes distributing 5% stocks dividends for the year 2023

2024-04-14
PIBC recommends distributing 2.5641% stocks dividends for the year 2023

2024-04-14
ABRAJ recommends converting the company from public shareholding to private shareholding

2024-04-14
NCI recommends distributing 12% cash dividends for the year 2023

2024-04-04
TRUST approves distributing 10% cash dividends for the year 2023

2024-04-04
Al-Quds Index stands-still with the start of April

2024-04-03
TIC approves distributing 15% cash dividends for the year 2023

2024-04-01
NSC recommends distributing 7% stocks dividends for the year 2023

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013
PHP Notice: Undefined index: archive in C:\Inetpub\wwwroot\sahem\menu.php on line 403